The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID 19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resource...
Gastrointestinal Diseases/therapy,
Gastrointestinal Diseases/diagnosis,
Liver Diseases/therapy,
Liver Diseases/diagnosis,
Immunity, Active/immunology,
Immunity, Active/drug effects,
Betacoronavirus,
Coronavirus Infections/prevention & control,
Pneumonia, Viral/prevention & control
Martín-Llahí, M;
Albillos, A;
Bañares, R;
Berzigotti, A;
García-Criado, M. Á;
Genescà, J;
Hernández-Gea, V;
Llop-Herrera, E;
Masnou-Ridaura, H;
Mateo, J;
Navascués, C. A;
Puente, Á;
Romero-Gutiérrez, M;
Simón-Talero, M;
Téllez, L;
Turon, F;
Villanueva, C;
Zarrabeitia, R;
García-Pagán, J. C.
Las enfermedades vasculares hepáticas, a pesar de su relativamente baja prevalencia, representan un problema de salud importante en el campo de las enfermedades hepáticas. Una característica común a muchas de estas enfermedades es que pueden causar hipertensión portal, con la elevada morbimortalidad...
Brooks, A. J;
Smith, P. J;
Cohen, R;
Collins, P;
Douds, A;
Forbes, V;
Gaya, D. R;
Johnston, B. T;
McKiernan, P. J;
Murray, C. D;
Sebastian, S;
Smith, M;
Whitley, L;
Williams, L;
Russell, R. K;
McCartney, S. A;
Lindsay, J. O.
The risks of poor transition include delayed and inappropriate transfer that can result in disengagement with healthcare. Structured transition care can improve control of chronic digestive diseases and long-term health-related outcomes. These are the first nationally developed guidelines on the transiti...
